Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene
- PMID: 16323009
- DOI: 10.1007/s00439-005-0096-7
Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene
Abstract
Mutations in OPA1 are the most frequent cause underlying autosomal dominant optic atrophy (adOA). Until now only few putative splicing mutations in the OPA1 gene have been investigated at the mRNA level and all these result in exon skipping. Here, we report the identification and cDNA analysis of four intronic and three exonic OPA1 gene mutations that cause a variety of splicing defects including activation of cryptic splice sites in either flanking exon or intron sequences, and a leaky splicing mutation. Our results show that cDNA analysis is of prime importance for the full evaluation of the effect of putative splicing mutations in the OPA1 gene.
Similar articles
-
Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicing.BMC Med Genet. 2017 Feb 28;18(1):22. doi: 10.1186/s12881-017-0383-x. BMC Med Genet. 2017. PMID: 28245802 Free PMC article.
-
Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.Ophthalmic Res. 2005 Jul-Aug;37(4):214-24. doi: 10.1159/000086862. Epub 2005 Jul 5. Ophthalmic Res. 2005. PMID: 16006781
-
A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1715-24. Invest Ophthalmol Vis Sci. 2002. PMID: 12036970
-
Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum.Mutat Res. 1998 Nov;411(3):179-214. doi: 10.1016/s1383-5742(98)00013-1. Mutat Res. 1998. PMID: 9804951 Review.
-
Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4. Mol Med Rep. 2016. PMID: 27150940 Free PMC article. Review.
Cited by
-
High-resolution en face images of microcystic macular edema in patients with autosomal dominant optic atrophy.Biomed Res Int. 2013;2013:676803. doi: 10.1155/2013/676803. Epub 2013 Nov 28. Biomed Res Int. 2013. PMID: 24369534 Free PMC article.
-
Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%.BMC Med Genet. 2012 Aug 2;13:65. doi: 10.1186/1471-2350-13-65. BMC Med Genet. 2012. PMID: 22857269 Free PMC article.
-
Multiethnic involvement in autosomal-dominant optic atrophy in Singapore.Eye (Lond). 2017 Mar;31(3):475-480. doi: 10.1038/eye.2016.255. Epub 2016 Nov 18. Eye (Lond). 2017. PMID: 27858935 Free PMC article.
-
Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies.BMC Bioinformatics. 2022 Nov 14;23(1):482. doi: 10.1186/s12859-022-05041-x. BMC Bioinformatics. 2022. PMID: 36376793 Free PMC article.
-
Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.Nucleic Acids Res. 2006;34(16):4630-41. doi: 10.1093/nar/gkl535. Epub 2006 Sep 8. Nucleic Acids Res. 2006. PMID: 16963498 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources